Kumar, Sarvesh ; Chandra Shekhar Reddy, L. ; Kumar, Yogesh ; Kumar, Amit ; Singh, Brajendra K. ; Kumar, Vineet ; Malhotra, Shashwat ; Pandey, Mukesh K. ; Jain, Rajni ; Thimmulappa, Rajesh ; Sharma, Sunil K. ; Prasad, Ashok K. ; Biswal, Shyam ; Van der Eycken, Erik ; DePass, Anthony L. ; Malhotra, Sanjay V. ; Ghosh, Balaram ; Parmar, Virinder S. (2012) Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: structure-activity analysis Archiv der Pharmazie, 345 (5). pp. 368-377. ISSN 0365-6233
Full text not available from this repository.
Official URL: http://onlinelibrary.wiley.com/doi/10.1002/ardp.20...
Related URL: http://dx.doi.org/10.1002/ardp.201100279
Abstract
The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important role in the pathogenesis of various inflammatory and autoimmune diseases. Small molecules that block these interactions have been targeted as potential therapeutic agents against acute and chronic inflammatory diseases. In an effort to identify potent intercellular cell adhesion molecule-1 (ICAM-1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism for their ICAM-1 inhibitory activities. The most active compound was found to be 79.
| Item Type: | Article |
|---|---|
| Source: | Copyright of this article belongs to John Wiley and Sons. |
| Keywords: | Arylalkyl Ketones; Benzophenones; Chalcones; Desoxybenzoins; Endothelial Cells; ICAM-1 |
| ID Code: | 89921 |
| Deposited On: | 02 May 2012 13:34 |
| Last Modified: | 14 Jun 2012 11:11 |
Repository Staff Only: item control page
